Pharmaceutical Technology1 天
Camrelizumab by Jiangsu Hengrui Medicine for Pancreatic Cancer: Likelihood of Approval
Camrelizumab is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for Pancreatic Cancer.
Pharmaceutical Technology1 天
Catequentinib hydrochloride by Advenchen Laboratories for Non-Small Cell Lung Cancer ...
Catequentinib hydrochloride is under clinical development by Advenchen Laboratories and currently in Phase II for Non-Small Cell Lung Cancer.